IRIS Accounts Production v24.2.0.383 07084141 director 1.12.22 30.11.23 30.11.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh070841412022-11-30070841412023-11-30070841412022-12-012023-11-30070841412021-11-30070841412021-12-012022-11-30070841412022-11-3007084141ns15:EnglandWales2022-12-012023-11-3007084141ns14:PoundSterling2022-12-012023-11-3007084141ns10:Director12022-12-012023-11-3007084141ns10:PrivateLimitedCompanyLtd2022-12-012023-11-3007084141ns10:SmallEntities2022-12-012023-11-3007084141ns10:AuditExemptWithAccountantsReport2022-12-012023-11-3007084141ns10:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-3007084141ns10:SmallCompaniesRegimeForAccounts2022-12-012023-11-3007084141ns10:FullAccounts2022-12-012023-11-3007084141ns10:OrdinaryShareClass12022-12-012023-11-3007084141ns10:RegisteredOffice2022-12-012023-11-3007084141ns5:CurrentFinancialInstruments2023-11-3007084141ns5:CurrentFinancialInstruments2022-11-3007084141ns5:ShareCapital2023-11-3007084141ns5:ShareCapital2022-11-3007084141ns5:RetainedEarningsAccumulatedLosses2023-11-3007084141ns5:RetainedEarningsAccumulatedLosses2022-11-3007084141ns5:ComputerEquipment2022-12-012023-11-3007084141ns5:ComputerEquipment2022-11-3007084141ns5:ComputerEquipment2023-11-3007084141ns5:ComputerEquipment2022-11-3007084141ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-11-3007084141ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-11-3007084141ns10:OrdinaryShareClass12023-11-30070841411ns10:Director12022-11-30070841411ns10:Director12021-11-30070841411ns10:Director12022-12-012023-11-30070841411ns10:Director12021-12-012022-11-30070841411ns10:Director12023-11-30070841411ns10:Director12022-11-30
REGISTERED NUMBER: 07084141 (England and Wales)















AP PHARMA SERVICES LTD

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2023






AP PHARMA SERVICES LTD (REGISTERED NUMBER: 07084141)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3

Report of the Accountants 6

AP PHARMA SERVICES LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 NOVEMBER 2023







DIRECTOR: Mr A Parry





REGISTERED OFFICE: Whitby Court
Abbey Road
Shepley
HUDDERSFIELD
West Yorkshire
HD8 8EL





REGISTERED NUMBER: 07084141 (England and Wales)





ACCOUNTANTS: FINLAYSON & CO
Whitby Court
Abbey Road
Shepley
HUDDERSFIELD
West Yorkshire
HD8 8EL

AP PHARMA SERVICES LTD (REGISTERED NUMBER: 07084141)

STATEMENT OF FINANCIAL POSITION
30 NOVEMBER 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Property, plant and equipment 4 750 1,106

CURRENT ASSETS
Debtors 5 10,198 17,534
Cash at bank 26,980 12,862
37,178 30,396
CREDITORS
Amounts falling due within one year 6 28,451 24,734
NET CURRENT ASSETS 8,727 5,662
TOTAL ASSETS LESS CURRENT
LIABILITIES

9,477

6,768

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 9,377 6,668
SHAREHOLDERS' FUNDS 9,477 6,768

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 8 April 2024 and were signed by:





Mr A Parry - Director


AP PHARMA SERVICES LTD (REGISTERED NUMBER: 07084141)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023

1. STATUTORY INFORMATION

AP Pharma Services Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Office Equipment - 20% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

AP PHARMA SERVICES LTD (REGISTERED NUMBER: 07084141)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 NOVEMBER 2023

4. PROPERTY, PLANT AND EQUIPMENT
Office
Equipment
£   
COST
At 1 December 2022
and 30 November 2023 7,044
DEPRECIATION
At 1 December 2022 5,938
Charge for year 356
At 30 November 2023 6,294
NET BOOK VALUE
At 30 November 2023 750
At 30 November 2022 1,106

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors - 8,089
Other debtors 10,198 9,445
10,198 17,534

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Taxation and social security 20,208 16,514
Other creditors 8,243 8,220
28,451 24,734

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary £1 100 100

AP PHARMA SERVICES LTD (REGISTERED NUMBER: 07084141)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 NOVEMBER 2023

8. DIRECTOR'S TRANSACTIONS

The following advances and credits to a director subsisted during the years ended 30 November 2023 and 30 November 2022:

2023 2022
£    £   
Mr A Parry
Balance outstanding at start of year 9,360 9,813
Amounts advanced 72,100 72,247
Amounts repaid (71,700 ) (72,700 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 9,760 9,360

AP PHARMA SERVICES LTD

REPORT OF THE ACCOUNTANTS TO THE DIRECTOR OF
AP PHARMA SERVICES LTD

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Statement of Financial Position. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

As described on the Statement of Financial Position you are responsible for the preparation of the financial statements for the year ended 30 November 2023 set out on pages two to seven and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.






FINLAYSON & CO
Whitby Court
Abbey Road
Shepley
HUDDERSFIELD
West Yorkshire
HD8 8EL


8 April 2024